标普和纳斯达克内在价值 联系我们

Estrella Immunopharma, Inc. ESLA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

共有 28 笔近期内部人交易记录记录,涉及 Estrella Immunopharma, Inc. (ESLA), 包括 3 笔买入8 笔卖出. 内部人买入总额为 $44.68B 内部人卖出总额为 $2.77M.

近期活跃的重要内部人包括 Jia Dengyao, Xu Jiandong, Liu Cheng. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — ESLA

日期 姓名 职位 交易类型 股数 平均价格 总价值 持股数量
2025-09-22 Jia Dengyao Director 未知 - - - -
2024-10-30 Xu Jiandong Chief Financial Officer 限制性股票授予 (RSU) 490,796 $0.82 $400K 490,796
2024-10-30 Liu Cheng Chief Executive Officer 限制性股票授予 (RSU) 490,796 $0.82 $400K 490,796
2024-08-14 Zhang Hong Other: Chairperson of the Board 未知 - - - 240,481
2023-09-29 Yang Weiguang Officer 未知 - - - -
2023-09-29 Tradeup Acquisition Sponsor Llc Officer 未知 - - - -
2023-09-29 Jiang Tao Officer 未知 - - - -
2023-09-29 Wen Luqi Officer 未知 - - - -
2023-09-29 Li Jianwei Officer 未知 - - - -
2023-09-29 Twigg Weston Officer 未知 - - - -
2023-09-29 Long James Officer 未知 - - - -
2023-09-29 Owl Creek Asset Management, L.p. 10 Percent Owner 其他(卖出) 255,000 $10.86 $2.77M -
2023-09-29 Eureka Therapeutics, Inc. 10 Percent Owner 处置 - - - 25,277,831
2023-09-29 Xu Jiandong Chief Financial Officer 处置 - - - 264,388
2023-09-29 Xu Pei Director 未知 - - - -
2023-09-29 Wu Fan Director 未知 - - - -
2023-09-29 Wu Xuejun Janelle Director 未知 - - - -
2023-09-29 Roberts Marsha Director 未知 - - - -
2023-09-29 Liu Cheng Chief Executive Officer 处置 - - - 297,437
2023-01-05 Owl Creek Asset Management, L.p. Director 未知 - - - 255,000
2022-03-04 Li Jianwei Co-chief Executive Officer 知情买入 141,970 $314,700.00 $44.68B 1,253,730
2021-07-14 Yang Weiguang Co-chief Executive Officer 未知 - - - -
2021-07-14 Tradeup Acquisition Sponsor Llc 10 Percent Owner 处置 - - - 1,145,760
2021-07-14 Wen Luqi Officer 未知 - - - -
2021-07-14 Li Jianwei 10 Percent Owner, Officer: Chairman and Co-CEO 未知 - - - 1,145,760
2021-07-14 Twigg Weston Director 处置 - - - 10,000
2021-07-14 Long James Director 处置 - - - 10,000
2021-07-14 Jiang Tao Director 处置 - - - 10,000
知情交易 — 公开市场买卖(最具参考价值) 非知情买入 — 奖励、期权行权、转换 非知情卖出 — 税务代扣、归属出售 中性 — 礼赠、信托、到期
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言